STOCK TITAN

Medirom Healthcare Technologies (MRM) Stock News

MRM Nasdaq

Welcome to our dedicated page for Medirom Healthcare Technologies news (Ticker: MRM), a resource for investors and traders seeking the latest updates and insights on Medirom Healthcare Technologies stock.

MEDIROM Healthcare Technologies Inc. reports developments across its Japan-based healthcare salon and health-tech businesses. The company operates and franchises wellness salons under the Re.Ra.Ku brand and develops digital preventive healthcare services through products such as Lav, the MOTHER Bracelet smart tracker and the REMONY remote monitoring system.

MRM news commonly covers Re.Ra.Ku salon activity, HealthTech partnerships, distributor agreements for MOTHER Bracelet and REMONY, World ID and Orb authentication initiatives in Japan, subsidiary financing, and treasury or capital-allocation actions involving digital assets. Updates also address American depositary share issuer communications, key performance indicators, and governance announcements tied to the company’s Nasdaq-listed security.

Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (Nasdaq: MRM) will present at the Benzinga Global Small Cap Conference on September 29, 2021, from 10:10am to 10:30am ET. Andrew Barwicki, Senior Vice President of Investor Relations, will lead the presentation, which will be available via live webcast for seven days post-event. MEDIROM operates 315 relaxation salons in Japan, including its flagship brand Re.Ra.Ku™, and has expanded into health tech and device development, including the Lav™ app and MOTHER Tracker™. More information can be found at medirom.co.jp/en.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.67%
Tags
conferences
-
Rhea-AI Summary

MEDIROM Healthcare Technologies (MRM) announced its August 2021 Key Performance Indicators (KPIs). The number of salons rose to 315, up from 284 a year prior, due to an acquisition. Total customers served remained steady at 66,323, with sales per customer increasing to JPY 6,592. The repeat customer ratio held at 81.3%. However, the operation ratio declined to 46.5%, down from 47.5% in the previous year. The data reflects the company's ongoing growth and stability while highlighting areas needing improvement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
73.23%
Tags
none
-
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (MRM) announced a share transfer agreement to acquire 100% of ZACC Kabushiki Kaisha, a luxury hair salon operator, for ¥370 million ($3.36 million). The acquisition will occur in two stages, with 60% of shares transferring on October 1, 2021, and the remaining shares on January 1, 2022. The strategy aims to enhance MEDIROM's portfolio by integrating high-end beauty services with its existing wellness offerings. This move represents MEDIROM's ongoing commitment to expanding its business in Japan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
73.23%
Tags
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM) reported significant growth for July 2021. The company operates 314 salons, a rise from 288 in July 2020, thanks to brand acquisitions. Total customers served surged to 70,912, reflecting a 14.6% increase compared to the previous year, marking the highest monthly record. Sales per customer increased to JPY 6,498 from JPY 6,276. The repeat customer ratio held steady at 81.0%, while the operation ratio improved to 48.1% from 43.3% in July 2020, indicating a recovery from COVID-19 impacts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.45%
Tags
none
-
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM) announced plans to release its interim financial results for the six months ending June 30, 2021, by the end of October 2021. As a foreign private issuer, MRM is not obligated to file quarterly reports but has been sharing monthly Key Performance Indicators (KPIs) since March 2021 to inform stakeholders about its business progress. The company operates 314 relaxation salons in Japan under the Re.Ra.Ku™ brand and has expanded into health tech and device sectors with initiatives like the MOTHER Tracker™.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.45%
Tags
-
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (Nasdaq: MRM) announced its key performance indicators for June 2021, reporting an increase in salons to 313 from 289 a year ago, fueled by a recent acquisition. The company served 68,069 customers, up from 51,686 in June 2020, marking recovery from COVID-19. Sales per customer rose slightly to JPY 6,350. The repeat customer ratio remained steady at 81.2%, while the operation ratio improved to 48.6% from 40.8% year-over-year, reflecting operational recovery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
none
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM) announced its May 2021 Key Performance Indicators (KPIs) reflecting significant growth as the number of salons increased to 313 from 289 a year prior. Total customers served rose sharply to 66,604 compared to 19,451 in May 2020, marking a recovery from COVID-19 impacts. Sales per customer grew slightly to JPY 6,370, and the operation ratio improved to 48.7%. However, the repeat customer ratio decreased to 80.6% from 84.5% as the prior year had a smaller new customer base.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
-
Rhea-AI Summary

MEDIROM (NasdaqCM: MRM) has signed a Master Manufacturing Agreement with Sanei Electronics for the production of its MOTHER Tracker®, a pioneering smart bracelet that harnesses thermoelectric energy from the wearer's body heat, eliminating the need for separate charging. This partnership aims to enhance operational efficiency and product quality with Canon Electronics as a subcontractor. Despite initial plans for overseas production, the COVID-19 pandemic prompted a shift to local manufacturing in Japan. The MOTHER Tracker® features continuous monitoring of health metrics and aims to facilitate data integration with healthcare providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
partnership
-
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (MRM) reported FY 2020 financial results with total revenue decreasing by 14.5% to $32.4 million, primarily due to COVID-19 lockdowns. The net loss stood at $5 million, with Adjusted EBITDA at -16.3%. SG&A expenses increased 22.6%/b% due to IPO costs. The company noted an increase in , aided by proceeds from the IPO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
Rhea-AI Summary

MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM) reported significant growth in its April 2021 Key Performance Indicators. The number of salons increased to 301 from 290 a year ago. Total customers served surged by 376% to 63,682 compared to 13,381 in April 2020, reflecting recovery from COVID-19. Sales per customer slightly decreased to JPY 6,250, influenced by promotional pricing for new salons. The repeat customer ratio dropped to 81.4%, while the operation ratio improved to 46.3%, up from 19.7% in the previous year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
none

FAQ

What is the current stock price of Medirom Healthcare Technologies (MRM)?

The current stock price of Medirom Healthcare Technologies (MRM) is $1.16 as of June 10, 2026.

What is the market cap of Medirom Healthcare Technologies (MRM)?

The market cap of Medirom Healthcare Technologies (MRM) is approximately 9.2M.